Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Kwon

Showing results (41-50 of 54) with videos related to

Pageof 6
Sort By:
Journal of Labelled Compounds & Radiopharmaceuticals|December 17, 2017
Synthesis and evaluation of an <sup>18</sup> F-labeled trifluoroborate derivative of 2-nitroimidazole for imaging tumor hypoxia with positron emission tomographyPaulo Sérgio Gonçalves Nunes, Zhengxing Zhang, Hsiou-Ting Kuo, et al.
Scientific Reports|November 29, 2025
Enhanced glycolysis and nicotinamide metabolism in HPV-positive head and neck cancerKatie A Shen, Jae-Jin Lee, Shu-Yun Cheng, et al.
Case Reports in Pulmonology|July 2, 2020
Review of Cases of E-Cigarette or Vaping Product Use-Associated Lung Injury (EVALI) and Brief Review of the LiteratureAmr Essa, Jeffrey Macaraeg, Nikhil Jagan, et al.
Nature Chemical Biology|June 8, 2022
Structure and activity of human TMPRSS2 protease implicated in SARS-CoV-2 activationBryan J Fraser, Serap Beldar, Almagul Seitova, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 12, 2025
Dual-Tracer Imaging on a Long-Axial-Field-of-View PET: A Proof-of-Principle Study with [<sup>18</sup>F]FGln and [<sup>18</sup>F]FDGDaniel Kwon, Elizabeth J Li, Christina Dulal, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|November 10, 2025
Team-Based Versus Technology-Based Supportive Cancer Care: A Mixed Methods Study of Multi-Site ImplementationSacha Moufarrej, Emily H Wood, Niharika Dixit, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 26, 2022
Targeting Refractory Mantle Cell Lymphoma for Imaging and Therapy Using C-X-C Chemokine Receptor Type 4 RadioligandsDaniel Kwon, Katsuyoshi Takata, Zhengxing Zhang, et al.
Urologic Oncology|November 18, 2019
Improving research for prostate cancer survivorship: A statement from the Survivorship Research in Prostate Cancer (SuRECaP) working groupVivek Narayan, Michael Harrison, Heather Cheng, et al.
The Lancet. Oncology|November 3, 2023
Single-dose <sup>177</sup>Lu-PSMA-617 followed by maintenance pembrolizumab in patients with metastatic castration-resistant prostate cancer: an open-label, dose-expansion, phase 1 trialRahul Aggarwal, Stephanie Starzinski, Ivan de Kouchkovsky, et al.
Frontiers in Oncology|April 24, 2023
Somatic alterations of <i>TP53</i> and <i>MDM2</i> associated with response to enfortumab vedotin in patients with advanced urothelial cancerTanya Jindal, Xiaolin Zhu, Rohit Bose, et al.
Pageof 6

Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
Journal of Labelled Compounds & Radiopharmaceuticals|December 17, 2017
Synthesis and evaluation of an <sup>18</sup> F-labeled trifluoroborate derivative of 2-nitroimidazole for imaging tumor hypoxia with positron emission tomographyPaulo Sérgio Gonçalves Nunes, Zhengxing Zhang, Hsiou-Ting Kuo, et al.
Scientific Reports|November 29, 2025
Enhanced glycolysis and nicotinamide metabolism in HPV-positive head and neck cancerKatie A Shen, Jae-Jin Lee, Shu-Yun Cheng, et al.
Case Reports in Pulmonology|July 2, 2020
Review of Cases of E-Cigarette or Vaping Product Use-Associated Lung Injury (EVALI) and Brief Review of the LiteratureAmr Essa, Jeffrey Macaraeg, Nikhil Jagan, et al.
Nature Chemical Biology|June 8, 2022
Structure and activity of human TMPRSS2 protease implicated in SARS-CoV-2 activationBryan J Fraser, Serap Beldar, Almagul Seitova, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 12, 2025
Dual-Tracer Imaging on a Long-Axial-Field-of-View PET: A Proof-of-Principle Study with [<sup>18</sup>F]FGln and [<sup>18</sup>F]FDGDaniel Kwon, Elizabeth J Li, Christina Dulal, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|November 10, 2025
Team-Based Versus Technology-Based Supportive Cancer Care: A Mixed Methods Study of Multi-Site ImplementationSacha Moufarrej, Emily H Wood, Niharika Dixit, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 26, 2022
Targeting Refractory Mantle Cell Lymphoma for Imaging and Therapy Using C-X-C Chemokine Receptor Type 4 RadioligandsDaniel Kwon, Katsuyoshi Takata, Zhengxing Zhang, et al.
Urologic Oncology|November 18, 2019
Improving research for prostate cancer survivorship: A statement from the Survivorship Research in Prostate Cancer (SuRECaP) working groupVivek Narayan, Michael Harrison, Heather Cheng, et al.
The Lancet. Oncology|November 3, 2023
Single-dose <sup>177</sup>Lu-PSMA-617 followed by maintenance pembrolizumab in patients with metastatic castration-resistant prostate cancer: an open-label, dose-expansion, phase 1 trialRahul Aggarwal, Stephanie Starzinski, Ivan de Kouchkovsky, et al.
Frontiers in Oncology|April 24, 2023
Somatic alterations of <i>TP53</i> and <i>MDM2</i> associated with response to enfortumab vedotin in patients with advanced urothelial cancerTanya Jindal, Xiaolin Zhu, Rohit Bose, et al.
Pageof 6